[Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment]

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):156-9. doi: 10.1016/s0213-005x(04)73056-6.
[Article in Spanish]

Abstract

We describe 16 HIV-infected patients with disseminated histoplasmosis (14 men, mean age 28 +/- 7.84 years), diagnosed at Hospital Eva Perón in Argentina during the period of October 1993 to July 2000. Disseminated histoplasmosis occurred in 5.3% of HIV-infected patients over the study period. The main symptoms included fever, weight loss and hepatosplenomegaly in 93.8%. Other relevant findings were respiratory compromise (56.3%), digestive symptoms (43.8%), mucocutaneous lesions (75%) and multiple lymphadenopathy (69%). Treatment consisted of amphotericin B 1 mg/kg/day up to a total dose of 1 g, followed by 400 mg/day of oral itraconazole. Mortality in the acute phase was 19% and 37.5% of patients relapsed.

Publication types

  • English Abstract
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology*
  • Adolescent
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Argentina / epidemiology
  • Female
  • Fever / etiology
  • Fluconazole / therapeutic use
  • Hepatomegaly / etiology
  • Histoplasmosis / diagnosis
  • Histoplasmosis / drug therapy
  • Histoplasmosis / epidemiology*
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Recurrence
  • Respiration Disorders / etiology
  • Splenomegaly / etiology
  • Weight Loss

Substances

  • Antifungal Agents
  • Itraconazole
  • Amphotericin B
  • Fluconazole